Quantitative Proteomic Analysis of Prostate Cancer
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Johns Hopkins University
Variable analysis
- LAPC4 and LNCaP prostate cancer cell lines
- Not explicitly mentioned
- RPMI media
- SILAC RPMI media
- Fetal bovine serum (FBS)
- Dialyzed fetal bovine serum (dFBS)
- Geneticin (G418)
- Puromycin
- 100 U/mL penicillin/streptomycin
- SILAC isotopes: 13C6 14N4-L-lysine (K6) and 13C6 15N4-L-arginine (R10)
- OptiPrep
- NuPAGE precast gels and NuOAFE MES running buffer
- Trypsin
- Lysyl endopeptidase
- BCA assay kit Pierce
- C18 SepPak columns and Oasis MAX extraction columns
- C18 solid-phase extraction disks
- Positive control: Mouse anti-ALIX (1A12) antibody from Santa Cruz Biotechnology
- Negative control: Rabbit anti-FUT8 antibody from Drs. Ruey-Bing Yang and Chen-Fen Tu (Institute of Biomedical Sciences, Academia Sinica, Taipei)
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!